John Wilson

7PUBLICATIONS
32CO-AUTHORS
Tumour immunologyMolecular targetsGenetically modified animalsBiomaterialsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 13, 2024
IL3-Driven T Cell-Basophil Crosstalk Enhances Antitumor Immunity.

Jian Wei, Colleen L Mayberry, Xiaoting Lv

|Mar 07, 2024
Transcriptome analysis reveals organ-specific effects of 2-deoxyglucose treatment in healthy mice.

Ann E Wells, John J Wilson, Sarah E Heuer

|Oct 26, 2023
Dystonin modifiers of junctional epidermolysis bullosa and models of epidermolysis bullosa simplex without dystonia musculorum.

Thomas J Sproule, Robert Y Wilpan, John J Wilson

|Apr 22, 2020
An intact C-terminal end of albumin is required for its long half-life in humans.

Jeannette Nilsen, Esben Trabjerg, Algirdas Grevys

|Jan 29, 2020
Abrogated AID Function Prolongs Survival and Diminishes Renal Pathology in the BXSB Mouse Model of Systemic Lupus Erythematosus.

Jing Zhu, Alayna N Hay, Ashley A Potter

|Jul 20, 2019
2-deoxy D-glucose treatment does not elicit a hair growth response in alopecia areata.

John P Sundberg, Kathleen A Silva, Victoria E Kennedy

Pageof 2

Frequent Collaborators

2 joint publications

Chih-Hao Chang

2 joint publications

John P Sundberg

2 joint publications

Jian Wei

2 joint publications

Derry C Roopenian